Erowid.org: Erowid Reference 571 : The N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prevents the neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) in rats : Finnegan KT, Skratt JJ, Irwin I, Langston JW

Erowid References Database

Finnegan KT, Skratt JJ, Irwin I, Langston JW. “The N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prevents the neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) in rats”. Neurosci Lett. 1990;105(3):300-6. <a name="ref">Finnegan KT, Skratt JJ, Irwin I, Langston JW.</a> <a href="/references/571">"The N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prevents the neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) in rats"</a> <i>Neurosci Lett</i>. 1990;105(3):300-6.
Text Abstract (this page) Full Text - English (private) Show Articles by Finnegan KT Skratt JJ Irwin I Langston JW Article IDs Erowid RefID: 571 PubMedID: unknown Collections Hofmann Collection MDMA Collection All References	Abstract Using the systemically active, non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist dextrorphan, we explored the role of the NMDA receptor-calcium channel complex in the toxic mechanism action of 3,4-methylenedioxymethamphetamine (MDMA). Rats were treated with MDMA, dextrorphan, or the combination of MDMA and increasing doses of dextrorphan, and then killed 10 days later for the assay of serotonin and dopamine in the striatum, hippocampus, and cortex. Dextrorphan totally prevented the serotonin-depleting effects of MDMA in the striatum, with a lessened but still significant blockade noted in the hippocampus and cortex. These findings may provide a clue to the molecular events underlying MDMA-induced neurotoxicity.
Comments and Responses to this Article #
Submit Comment

[ Cite HTML ]